ICU sedation, delirium & recovery

Remimazolam versus propofol for sedation in mechanically ventilated intensive care unit (ICU) patients: A systematic review and meta-analysis of randomized controlled trials

J Crit CarePublished Systematic review and meta-analysis of randomized controlled trials

Pooled result · Percentage of time within the target sedation rangeResult — go to the resultMD −0.45% 95% CI −2.46 to 1.55

Authors' conclusion

Remimazolam probably results in little to no difference in sedation efficacy compared with propofol in mechanically ventilated ICU patients. However, uncertainty remains regarding clinical and safety outcomes. Larger multinational RCTs are warranted to clarify these effects.

Study context

Population
Mechanically ventilated ICU patients
Participants
705 participants
Comparison
Remimazolam vs propofol
Outcome
Percentage of time within the target sedation range

Pooled result

As reported in the abstract

Percentage of time within the target sedation range

MD

−0.45%

95% CI −2.46 to 1.55

P = 0.56

Remimazolamvs Propofol
MD −0.45% (95% CI −2.46 to 1.55); P = 0.56

Secondary outcomes

Sedation success rate, 28-day mortality, ICU mortality, ICU length of stay, and duration of mechanical ventilation

No significant differences were detected
  • Several estimates were imprecise

Safety

Safety outcomes (adverse events leading to dose reduction, hypotension, and delirium)

No significant differences were detected
  • Several estimates were imprecise

Original publication

Remimazolam versus propofol for sedation in mechanically ventilated ICU patients: A systematic review and meta-analysis of randomized controlled trials. J Crit Care. Published 4 November 2026. doi:10.1016/j.jcrc.2026.155798

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.